Access cutting-edge cystic fibrosis treatment through this clinical trial at a research site in Baltimore. Study-provided care at no cost to qualified participants.
Access cystic fibrosis specialists in Baltimore at no cost
This study follows strict safety protocols and ethical guidelines
All study-related cystic fibrosis treatment provided free
CMTX-101 is a bacterial biofilm disrupting monoclonal antibody being developed as an adjunctive therapy to standard of care antibiotics. The goal of this clinical trial is to assess the safety and tolerability of CMTX-101 in people with cystic fibrosis (pwCF). The main questions the study aims to answer are: * Are single doses of CMTX-101 IV infusion safe and tolerated * What is the pharmacokinetic (PK) profile of single doses of CMTX-101 * Do single doses of CMTX-101 induce development of ant
Sponsor: Clarametyx Biosciences, Inc.
Check if you qualify for this cystic fibrosis clinical trial in Baltimore, MD
If you're searching for cystic fibrosis treatment options in Baltimore, MD, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Baltimore research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cystic fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.